Abstract
The incidence of brain metastasis from hepatocellular carcinoma (HCC) is increasing because of the improved survival outcome of HCC patients, but the prognosis of these patients is extremely poor. HCC patients with brain metastasis were investigated to identify their prognostic factors for overall survival. Patients with brain metastasis from HCC who had been treated with whole-brain radiotherapy (WBRT) in five hospitals were enrolled in the study. The medical records of the patients were reviewed, and the clinical factors were analyzed to identify the prognostic factors for overall survival. Of the total of 97 patients who were enrolled in the study, 83 were male and the median age at the brain metastases was 56.6 years. Motor weakness (43.3 %) and headache (41.2 %) were common presenting symptoms. The median AFP level was 4180 ng/ml, and 81 patients were assessed as belonging to Child-Pugh classification A upon the diagnosis of brain metastasis. WBRT alone in 71 patients, surgery or radiosurgery combined with WBRT as the adjuvant setting in 18 patients, and WBRT as salvage treatment in 8 patients were performed. The median overall survival of the patients was 3.5 months. In the multivariate analysis, the ECOG performance stat...Continue Reading
References
Feb 22, 1990·The New England Journal of Medicine·R A PatchellB Young
May 1, 1996·Neuroradiology·K MurakamiT Ichikawa
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·L GasparR Byhardt
Apr 3, 1998·Journal of Neuro-oncology·M KimJ K Roh
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·E WeltmanD B Wajsbrot
Feb 18, 2003·Journal of Neuro-oncology·Bruce E PollockPaula J Schomberg
May 26, 2004·Lancet·David W AndrewsWalter J Curran
Jul 21, 2004·Surgical Neurology·Lin ChangMing-Chien Kao
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·José LorenzoniMarc Levivier
Oct 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Paul W SperdutoWalter Curran
Oct 25, 2008·Journal of Neuro-oncology·Hye Jin ChoiNae Choon Yoo
Jan 8, 2011·The Oncologist·Yu-Yun ShaoChih-Hung Hsu
Feb 2, 2012·BMC Cancer·Xiao-Bing JiangYong-Gao Mou
May 1, 2012·Neuro-oncology·Jill S Barnholtz-SloanMichael W Kattan
Dec 3, 2013·BMC Cancer·Moon-Soo HanShin Jung
Jun 7, 2014·Brain Tumor Research and Treatment·Tae Yong ParkYoung Gou Park
Jul 24, 2014·Journal of Neuro-oncology·Kyung Su KimSung W Ha
Jul 27, 2014·Journal of Neuro-oncology·Seungtaek LimHye Jin Choi
Citations
Feb 23, 2019·International Journal of Clinical Oncology·Hee Chul NamSi Hyun Bae
May 7, 2019·Gut and Liver·UNKNOWN Korean Liver Cancer Association, UNKNOWN National Cancer Center
Mar 23, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Tackeun KimChae-Yong Kim
Apr 28, 2017·Oncotarget·Shanshan WangJiefu Huang
Jul 5, 2019·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·UNKNOWN Korean Liver Cancer Association (KLCA), UNKNOWN National Cancer Center (NCC), Goyang, Korea
Apr 19, 2018·Neurosurgery·Lucas GilbrideWilliam A Hall
Jul 4, 2018·International Journal of Clinical Oncology·Takeshi OkudaYoko Nakasu
Jan 4, 2017·Cancer Biology & Therapy·Kenya KamimuraShuji Terai
Jul 16, 2016·The British Journal of Radiology·Chan Woo WeeJung Hwan Yoon
Mar 2, 2021·Frontiers in Oncology·Ji ZhangXiance Jin
Aug 10, 2021·World Journal of Clinical Cases·Hai-Yi LongBao-Xian Liu